Industry waits for fallout from Cabilly.
Waltz
Emily
E
D000911:Antibodies, Monoclonal / Q000737:chemistry*; D001709:Biotechnology / Q000331:legislation & jurisprudence / Q000379:methods*; D006801:Humans; D007221:Industry; D010330:Patents as Topic; D012109:Research Support as Topic; D012306:Risk
D000911:Antibodies, Monoclonal